Goals and Objectives of Genetic Cloning
In modern medical practice, DNA cloning technologies provide powerful tools for human genome analysis. The primary goals include:
- Genetic mapping — constructing detailed genetic maps of an organism.
- Determining chromosomal localization of defects leading to pathology.
- Prenatal diagnosis of severe inherited diseases before birth.
Through these approaches, scientists have precisely mapped the chromosomal locations of many severe conditions, such as sickle cell anemia, phenylketonuria, and Duchenne muscular dystrophy.
Restriction Fragment Length Polymorphism (RFLP)
The foundation of RFLP analysis lies in alterations of the primary DNA structure resulting from various mutations (point mutations, deletions, or insertions of additional nucleotides).
The underlying mechanism is that any alterations in the primary sequence inevitably shift, eliminate, or create new restriction sites. When biological samples are treated with restriction endonucleases (restriction enzymes), mutant DNA is cleaved into fragments whose lengths differ significantly from those of healthy DNA.
In clinical practice, the RFLP phenomenon is widely used to screen patients for carrier status of pathogenic genes. For example, the method reliably identifies heterozygous parents in families at high risk for transmitting sickle cell anemia.
Analysis Using Allele-Specific Probes
Another powerful molecular diagnostic tool involves synthetic short oligodeoxynucleotides acting as probes. To visualize the results, these molecules are labeled with the P³² isotope.
Testing requires two types of probes:
- A probe containing the normal (wild-type) nucleotide sequence.
- A probe complementary to the DNA sequence containing the target mutation.
During the analysis, the patient's genetic material is tested using these specific molecules. Hybridization of the sample with a specific probe provides a definitive conclusion regarding the presence or absence of a specific genetic defect.
Genetic Polymorphism and Clinical Manifestations
Individual human responses to environmental factors (diet, toxins, drugs, infectious agents) are driven by multiple genetic polymorphisms, particularly involving various isoforms of detoxification enzymes.
Clinical examples of polymorphism:
- Lactose intolerance: A genetically determined inability to digest and absorb fresh milk.
- Alcohol sensitivity: Distinct ethnic variations (particularly in Asian populations) linked to mutations in the alcohol dehydrogenase gene.
- Solanine sensitivity: The toxic glycoside from green potato tubers inhibits pseudocholinesterase; the reaction to this toxin depends on the genetic variant of this enzyme.
Hereditary Predisposition Multiple polymorphisms in receptors, detoxification enzymes, and cell cycle regulatory proteins underlie the familial predisposition to several multifactorial disorders. These include diabetes mellitus, atherosclerosis, malignancies, psychiatric disorders, as well as pulmonary, cardiac, and renal diseases. Notably, a genetic predisposition is clinically expressed only when specific environmental triggers are present.